Back to search

Article

CAR NK Cells: The Future Is Now

2023-01-17

Abstract excerpt

Chimeric antigen receptor (CAR) T cell therapy has been a great success in CD19+ hematological diseases. Natural killer (NK) CAR cells offer an alternative to CAR T cells with an intrinsic potential for universal off-the-shelf cell therapeutics. The choice of cell type and the choice of CAR are both relevant for the feasibility, effectivity, engraftment, persistence, side effects, and safety of the cell therapy. U...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
08005938-3fd0-5305-87cb-55601111eb24
DOI
10.1146/annurev-cancerbio-061521-082320
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CAR NK Cells: The Future Is NowDOI 10.1146/annurev-cancerbio-061521-082320
Select a neighboring publication to make it the new centre.